Fundz

Phenaros Pharmaceuticals raised pre-seed funding led by Nordic Science Investments to enhance its AI-driven drug discovery platform.

PRIVATEJan 30, 2025

Round Type

Pre-Seed

UppsalaBiotechnologyArtificial IntelligenceTherapeuticsMachine LearningPharmaceutical

Investors

Almi InvestMonesiLänsförsäkringar UppsalaNordic Science Investments

Description

Phenaros Pharmaceuticals has secured pre-seed funding to further develop its AI-driven drug discovery platform. The capital will be used to expand its robotized facilities and enhance its proprietary data, supporting its commercial operations.

Quick answer

Phenaros Pharmaceuticals raised an undisclosed amount in a Pre-Seed round, dated January 30, 2025. Investors: Almi Invest, Monesi, Länsförsäkringar Uppsala and Nordic Science Investments. Phenaros Pharmaceuticals is based in Uppsala, Uppsala County, Sweden.

How much did Phenaros Pharmaceuticals raise?
Phenaros Pharmaceuticals raised an undisclosed amount in a Pre-Seed round on January 30, 2025.
Who invested in Phenaros Pharmaceuticals?
Almi Invest, Monesi, Länsförsäkringar Uppsala and Nordic Science Investments are named as investors in this round.
What does Phenaros Pharmaceuticals do?
Phenaros Pharmaceuticals is a Swedish drug discovery company that combines AI, automation, and phenomics to streamline the process of discovering new and repurposed drugs, particularly for rare diseases.
Where is Phenaros Pharmaceuticals based and how big is it?
Phenaros Pharmaceuticals is based in Uppsala, Uppsala County, Sweden. Fundz records about 8 employees.
Who are the decision-makers at Phenaros Pharmaceuticals?
Fundz holds 1 contact at Phenaros Pharmaceuticals. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as Phenaros Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • Newronika raised $14M (Series B) on February 13, 2025.
  • Cursor raised $105M (Funding Round) on January 15, 2025.
  • Elea raised $4.3M (Seed) on March 12, 2025.
  • Acurx Pharmaceuticals raised $3.4M (Seed) on March 10, 2025.
  • BioPhy raised $6.6M on March 4, 2025.
  • SimCare AI raised $2M (Seed) on February 27, 2025.

Who to call at Phenaros Pharmaceuticals, and when

A new round usually means Phenaros Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Phenaros Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Phenaros Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Phenaros Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Phenaros Pharmaceuticals

Location

Uppsala, Uppsala County, Sweden

About

Phenaros Pharmaceuticals is a Swedish drug discovery company that combines AI, automation, and phenomics to streamline the process of discovering new and repurposed drugs, particularly for rare diseases. Founded in 2021, it originated as a spin-off from Uppsala University and SciLifeLab. The company aims to expedite the drug discovery process by integrating AI into its research workflows. Phenaros also offers its discovery platform to other organizations through partnerships, highlighting the potential of AI in transforming drug development.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Phenaros Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Phenaros Pharmaceuticals's next move

See what Strategic adds

Phenaros Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.